Marksans Pharma Limited has informed the Exchange regarding 'Annual General Meeting Notice'.
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has notified the stock exchanges about its 33rd Annual General Meeting (AGM) scheduled for Friday, August 8, 2025, at 9:00 A.M. via video conferencing. The Board is recommending a dividend of ₹0.80 (80%) per equity share of Re. 1 face value, with August 1, 2025 as the record date and payment expected on or after August 21, 2025. Shareholders will vote on adopting FY25 audited financial statements, re-appointing Mrs. Sandra Saldanha as director, appointing Mr. Srinivas Mishra as an Independent Director for five years, and appointing M/s Jinesh Dedhia & Associates as Secretarial Auditor for five years at a proposed remuneration of ₹1,30,000 for FY 2025-26. E-voting will run from August 5, 2025 (9:00 A.M.) to August 7, 2025 (5:00 P.M.). Two special resolutions also seek approval to amend the 'Marksans Employees Stock Option Scheme 2024' to extend ESOP benefits to employees of subsidiary companies, covering 23,00,000 ungranted options.
Routine AGM notice, but includes a meaningful 33% hike in dividend (from ₹0.60 to ₹0.80 per share) and an ESOP scheme expansion to subsidiary employees, which may lead to some dilution later. No immediate major impact on share price expected from the notice itself.